Alda M et al., 2016-06-09: Double-blind randomised crossover trial in 37 patients with bipolar disorder on lamotrigine: 195 mg/day methylene blue improved residual depression and anxiety versus 15 mg, but had no significant effect on cognitive symptoms.
The active dose of methylene blue significantly improved symptoms of depression both on the Montgomery-Asberg Depression Rating Scale and Hamilton Rating Scale for Depression (P = 0.02 and 0.05 in last-observation-carried-forward analysis).
abstract (vol 210, pp 54-59)
Alda M et al., 2016-06-09: Double-blind randomised crossover trial in 37 patients with bipolar disorder on lamotrigine: 195 mg/day methylene blue improved residual depression and anxiety versus 15 mg, but had no significant effect on cognitive symptoms. Study type: randomized trial.
